Nahla E. El‐Ashmawy

1.4k total citations
67 papers, 1.1k citations indexed

About

Nahla E. El‐Ashmawy is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Nahla E. El‐Ashmawy has authored 67 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 18 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Nahla E. El‐Ashmawy's work include Immunotherapy and Immune Responses (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Circular RNAs in diseases (6 papers). Nahla E. El‐Ashmawy is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Circular RNAs in diseases (6 papers). Nahla E. El‐Ashmawy collaborates with scholars based in Egypt. Nahla E. El‐Ashmawy's co-authors include Hoda A. El‐Bahrawy, Eman G. Khedr, Naglaa F. Khedr, Kamal Okasha, Yusuf A. Haggag, Mohamed L. Salem, Eman M. Khedr, Eslam E. Abd El-Fattah, Abdel‐Aziz A. Zidan and El‐Zeiny M. Ebeid and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Nahla E. El‐Ashmawy

64 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nahla E. El‐Ashmawy Egypt 21 380 182 167 154 152 67 1.1k
Haiyan Xu China 21 531 1.4× 157 0.9× 182 1.1× 113 0.7× 109 0.7× 105 1.3k
Meiqi Wang China 18 623 1.6× 177 1.0× 203 1.2× 139 0.9× 80 0.5× 90 1.2k
Min Su China 22 703 1.9× 187 1.0× 241 1.4× 197 1.3× 94 0.6× 63 1.5k
Jung‐Lye Kim South Korea 21 502 1.3× 157 0.9× 105 0.6× 135 0.9× 133 0.9× 35 1.0k
Zuqing Su China 23 491 1.3× 95 0.5× 111 0.7× 193 1.3× 129 0.8× 43 1.2k
Chao Guo China 19 520 1.4× 120 0.7× 196 1.2× 167 1.1× 85 0.6× 53 1.1k
Tae Young Oh South Korea 21 450 1.2× 129 0.7× 160 1.0× 151 1.0× 281 1.8× 34 1.0k
Hong Luan China 20 528 1.4× 111 0.6× 201 1.2× 78 0.5× 169 1.1× 55 1.2k
Jamshid Karimi Iran 24 480 1.3× 97 0.5× 127 0.8× 114 0.7× 106 0.7× 82 1.5k

Countries citing papers authored by Nahla E. El‐Ashmawy

Since Specialization
Citations

This map shows the geographic impact of Nahla E. El‐Ashmawy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nahla E. El‐Ashmawy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nahla E. El‐Ashmawy more than expected).

Fields of papers citing papers by Nahla E. El‐Ashmawy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nahla E. El‐Ashmawy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nahla E. El‐Ashmawy. The network helps show where Nahla E. El‐Ashmawy may publish in the future.

Co-authorship network of co-authors of Nahla E. El‐Ashmawy

This figure shows the co-authorship network connecting the top 25 collaborators of Nahla E. El‐Ashmawy. A scholar is included among the top collaborators of Nahla E. El‐Ashmawy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nahla E. El‐Ashmawy. Nahla E. El‐Ashmawy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Ashmawy, Nahla E., et al.. (2025). Berberine‐Induced Cytotoxicity in Breast Cancer Is Mediated by Reversal of EMT and Repression of Sirtuin 1/AKT Signaling Pathways. Journal of Biochemical and Molecular Toxicology. 39(7). e70375–e70375.
2.
Khedr, Eman G., et al.. (2024). Prostate cancer and the cell cycle: Focusing on the role of microRNAs. Gene. 928. 148785–148785. 4 indexed citations
3.
El‐Ashmawy, Nahla E., et al.. (2024). Competing endogenous RNAs network and therapeutic implications: New horizons in disease research. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1868(1). 195073–195073. 3 indexed citations
4.
El‐Ashmawy, Nahla E., et al.. (2021). Inhibition of PKC/MEK pathway suppresses β1-integrin and mitigates breast cancer cells proliferation. Toxicology Reports. 8. 1530–1537. 3 indexed citations
5.
El‐Ashmawy, Nahla E., Mohamed L. Salem, Eslam E. Abd El-Fattah, & Eman G. Khedr. (2021). Targeting CD166+ lung cancer stem cells: Molecular study using murine dendritic cell vaccine. Toxicology and Applied Pharmacology. 429. 115699–115699. 27 indexed citations
6.
El‐Ashmawy, Nahla E., et al.. (2020). Modulatory Effect of Silymarin on Apoptosis in Testosterone -Induced Benign Prostatic Hyperplasia in Rats. Pathology & Oncology Research. 26(3). 1947–1956. 11 indexed citations
7.
8.
El‐Ashmawy, Nahla E., Kamal Okasha, Tarek M. Mostafa, et al.. (2020). The plausible mechanisms of tramadol for treatment of COVID-19. Medical Hypotheses. 146. 110468–110468. 20 indexed citations
9.
El‐Ashmawy, Nahla E., et al.. (2019). Activation of EMT in colorectal cancer by MTDH/NF-κB p65 pathway. Molecular and Cellular Biochemistry. 457(1-2). 83–91. 30 indexed citations
10.
11.
El‐Ashmawy, Nahla E., et al.. (2018). Docosahexaenoic acid-flurbiprofen combination ameliorates metaflammation in rats fed on high-carbohydrate high-fat diet. Biomedicine & Pharmacotherapy. 109. 233–241. 2 indexed citations
12.
El‐Ashmawy, Nahla E., et al.. (2018). Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study. Clinical and Experimental Medicine. 18(4). 535–546. 4 indexed citations
13.
El‐Ashmawy, Nahla E., et al.. (2018). Roflumilast, type 4 phosphodiesterase inhibitor, attenuates inflammation in rats with ulcerative colitis via down-regulation of iNOS and elevation of cAMP. International Immunopharmacology. 56. 36–42. 21 indexed citations
14.
El‐Ashmawy, Nahla E., et al.. (2018). Upregulation of PPAR-γ mediates the renoprotective effect of omega-3 PUFA and ferulic acid in gentamicin-intoxicated rats. Biomedicine & Pharmacotherapy. 99. 504–510. 39 indexed citations
15.
El‐Ashmawy, Nahla E., et al.. (2017). Downregulation of iNOS and elevation of cAMP mediate the anti-inflammatory effect of glabridin in rats with ulcerative colitis. Inflammopharmacology. 26(2). 551–559. 39 indexed citations
16.
17.
El‐Ashmawy, Nahla E., et al.. (2015). In vitro and in vivo studies of the immunomodulatory effect of Echinacea purpurea on dendritic cells. Journal of Genetic Engineering and Biotechnology. 13(2). 185–192. 19 indexed citations
18.
El‐Bahrawy, Hoda A., et al.. (2014). Effect of Diet Intake Imbalance in Hepatocellular Carcinoma Progression. International Journal of Biology. 6(2). 1 indexed citations
19.
El‐Ashmawy, Nahla E., et al.. (2014). Biochemical/metabolic changes associated with hepatocellular carcinoma development in mice. Tumor Biology. 35(6). 5459–5466. 19 indexed citations
20.
El‐Ashmawy, Nahla E., et al.. (2014). Evaluation of oxidative stress and DNA damage in cement and tannery workers in Egypt. Inhalation Toxicology. 26(5). 289–298. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haiyan Xu Breakdown of academic impact, for papers by Meiqi Wang Breakdown of academic impact, for papers by Min Su Breakdown of academic impact, for papers by Jung‐Lye Kim Breakdown of academic impact, for papers by Zuqing Su Breakdown of academic impact, for papers by Chao Guo Breakdown of academic impact, for papers by Tae Young Oh Breakdown of academic impact, for papers by Hong Luan Breakdown of academic impact, for papers by Jamshid Karimi
Rankless by CCL
2026